Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinson's disease, but not Parkinson plus patients, from an Indian population

Journal of the Neurological Sciences

Volumn 279, Issue 1-2, 2009, Pages 39-42

  Varghese, Merina ^a   Pandey, Mritunjay ^a   Samanta, Ananda ^a,b   Gangopadhyay, Prasanta Kumar ^b   Mohanakumar, Kochupurackal P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b CALCUTTA NATIONAL MEDICAL COLLEGE   (India)

Author keywords

Electron transport chain; Mitochondria; NADH dehydrogenase; Parkinsonism; Platelets; Succinate dehydrogenase

Indexed keywords

NADH COENZYME Q DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MITOCHONDRIAL MEMBRANE; PARKINSON DISEASE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; ELECTRON TRANSPORT COMPLEX I; ENZYME ACTIVATION; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SUCCINATE DEHYDROGENASE;

EID: 61449115702     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.12.021     Document Type: Article

References (46)

1. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54 (1990) 823-827
2. 10 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55 (1990) 2142-2145
3. Janetzky B., Hauck S., Youdim M.B.H., Riederer P., Jellinger K., Pantucek F., Zochling R., Boissl K.W., and Reichmann H. Unaltered aconitase activity but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 169 (1994) 126-128
4. Gu M., Owen A.D., Toffa S.E.K., Cooper J.M., Dexter D.T., Jenner P., Marsden C.D., and Schapira A.H.V. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci 158 (1998) 24-29
5. Bindoff LA, Birch-Machin M, Cartlidge NEF, Parker Jr. WD, Turnbull DM. Mitochondrial function in Parkinson's disease. Lancet 334 (1989) 49
6. Shoffner J.M., Watts R.L., Juncos J.L., Torroni L., and Wallace D.C. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 30 (1991) 332-339
7. Nakagawa-Hattori Y., Yoshino H., Kondo T., Mizuno Y., and Horai S. Is Parkinson's disease a mitochondrial disorder?. J Neurol Sci 107 (1992) 29-33
8. Cardellach F., Martí M.J., Fernández-Solá J., Marín C., Hoek J.B., Tolosa E., and Urbano-Márquez A. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 43 (1993) 2258-2262
9. Blin O., Desnuelle C., and Rascol O. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 125 (1994) 95-101
10. Schapira A.H. Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal. Mov Disord 9 (1994) 125-138
11. Barroso N., Campos Y., Huertas R., Esteban J., Molina J.A., Alonso A., Gutierrez-Rivas E., and Arenas J. Respiratory chain activities in lymphocytes from untreated patients with Parkinson's disease. Clin Chem 39 (1993) 667-669
12. Mytinileou C., Werner P., Molinari S., Di-Rocco A., Cohen G., and Yahr M.D. Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease. J Neural Transm Parkinson's Dis Sect 8 (1994) 223-228
13. Mann V.M., Cooper J.M., Krige D., Daniel S.E., Schapira A.H.V., and Marsden C.D. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115 (1992) 333-342
14. Anderson J.J., Ferrari R., Davis T.L., Baronti F., Chase T.N., and Dagani F. No evidence for altered muscle mitochondrial function in Parkinson's disease. J Neurol Neurosurg Psychiatr 56 (1993) 477-480
15. Didonato S., Zeviani M., Giovannini P., Savarese N., Rimoldi M., Mariotti C., and Girotti F Caraceni T. Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology 43 (1993) 2262-2268
16. Reichmann H., Janetzky B., Bischof F., Seibel P., Schols L., Kuhn W., and Przuntek H. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. Eur Neurol 34 (1994) 263-267
17. Yoshino H., Nakagawa-Hattori Y., Kondo T., and Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm 4 (1992) 27-34
18. Martin M.A., Molina J.A., Jiminez-Jiminez F.J., Benito-Leon J., Orti-Pareja M., Campos Y., and Arenas J. Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Neurology 46 (1996) 1343-1346
19. Langer S.Z., and Galzin A.M. Studies on the serotonin transporter in platelets. Experientia 44 (1988) 127-130
20. Frankhauser P., Grimmer Y., Bugert P., Deuschle M., Schmidt M., and Schloss P. Characterization of the neuronal dopamine transporter DAT in human blood platelets. Neurosci Lett 399 (2006) 197-201
21. Stahl S.M. The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry 34 (1977) 509-516
22. 10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 42 (1997) 261-264
23. 10 in Parkinson's disease. J Neural Transm 107 (2000) 41-48
24. Ferrarese C., Zoia C., Pecora N., Piolti R., Frigo M., Bianchi G., Sala G., Begni B., Riva R., and Frattola L. Reduced platelet glutamate uptake in Parkinson's disease. J Neural Transm 106 (1999) 685-692
25. Oreland L., Johansson F., and Ekstedt J. Dose regimen of deprenyl (selegiline) and platelet MAO activities. Acta Neurol Scand Suppl 95 (1983) 87-89
26. Lee D.H., Mendoza M., Dvorozniak M.T., Chung E., van Woert M.H., and Yahr M.D. Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy. J Neural Transm Park Dis Dement Sect 1 (1989) 189-194
27. Benecke R., Strümper P., and Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 116 (1993) 1451-1463
28. Esteves A.R., Domingues A.F., Ferreira I.L., Januário C., Swerdlow R.H., Oliveira C.R., and Cardoso S.M. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion 8 (2008) 219-228
29. Parker Jr. W.D., Boyson S.J., and Parks J.K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26 (1989) 719-723
30. Haas R.H., Nasirian F., Nakano K., Ward D., Pay M., Hill R., and Shults C.W. Low platelet mitochondrial Complex I and Complex II/III activity in early untreated Parkinson's disease. Ann Neurol 37 (1995) 714-722
31. Bravi D., Anderson J.J., Dagani F., Davis T.L., Ferrari R., Gillespie M., and Chase T.N. Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Mov Disord 7 (1992) 228-231
32. Hanagasi H.A., Ayribas D., Baysal K., and Emre M. Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's disease. Int J Neurosci 115 (2005) 479-493
33. Rajkumar R., Banerjee J., Gunturi H.B., Trivedi R., and Kashyap V.K. Phylogeny and antiquity of M macrohaplogroup inferred from complete mtDNA sequence of Indian specific lineages. BMC Evol Biol 5 (2005) 26
34. Passarino G., Semino O., Quintana-Murci L., Excoffier L., Hammer M., and Santachiara-Benerecetti A.S. Different genetic components in Ethiopian population, identified by mtDNA and Y-chromosome polymorphisms. Am J Hum Genet 62 (1998) 420-434
35. Kivisild T., Bamshad M.J., Kaldma K., Metspalu M., Reidla M., Laos S., Parik J., Waltkins W.S., Dixon M.E., Papiha S.S., Mastana S.S., Mir M.R., Ferak V., and Villems R. Deep common ancestry of Indian and western-Eurasian mitochondrial DNA lineages. Curr Biol 9 (1999) 1331-1334
36. Yao Y.G., Kong Q.P., Bandelt H.J., Kivisild T., and Zheng Y.P. Phylogeographic differentiation of mitochondrial DNA in Han Chinese. Am J Hum Genet 70 (2002) 635-651
37. Kong Q.-P., Yao Y.-G., Liu M., Shen S.-P., Chen C., Zhu C.-L., Palanichamy M.G., and Zhang Y.-P. Mitochondrial DNA sequence polymorphisms of five ethnic populations from northern China. Hum Genet 113 (2003) 391-405
38. Shinde S., and Pasupathy K. Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: preliminary study. Neurol India 54 (2006) 390-393
39. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
40. Shults C.W., Nasirian F., Ward D.M., Nakano K., Pay M., Hill L.R., and Haas R.H. Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism. Neurology 45 (1995) 344-348
41. Ackrell B.A., Kearney E.B., and Singer T.P. Mammalian succinate dehydrogenase. Methods Enzymol 53 (1978) 466-483
42. Krige D., Carroll M.T., Cooper J.M., Marsden C.D., and Schapira A.H. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 32 (1992) 782-788
43. Schapira A.H., Mann V.M., Cooper J.M., Krige D., Jenner P.J., and Marsden C.D. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol Suppl 32 (1992) 116-124
44. Blake C.I., Spitz E., Leehey M., Hoffer B.J., and Boyson S.J. Platelet mitochondrial respiratory chain function in Parkinson's disease. Mov Disord 12 (1997) 3-8
45. Borland M.K., Mohanakumar K.P., Rubinstein J.D., Keeney P.M., Xie J., Capaldi R.A., Dunahm L.D., Trimmer P.A., and Bennett Jr. J.P. Relationships among molecular, genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues. BBA - Molecular Basis of Disease 1792 (2009) 68-74
46. Schapira A.H. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7 (2008) 97-109